Vimarsana
Biggest News Aggregation in the World

Omar Nadeem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Omar Nadeem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Omar Nadeem Today - Breaking & Trending Today

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms - Vimarsana News

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Sonu Nigam responds to Pakistani singer Omer Nadeem's plagiarism accusations - Vimarsana News

Sonu Nigam responds to Pakistani singer Omer Nadeem's plagiarism accusations

Sonu Nigam apologised to Omer Nadeem, who had recently accused Sonu of plagiarising his song Aye Khuda with the track Sun Zara released by T-series.

Sarfaraz Ahmed's future with Gladiators gets murkier as Moin Khan turns on his captain - Vimarsana News

Sarfaraz Ahmed's future with Gladiators gets murkier as Moin Khan turns on his captain

Sarfaraz Ahmed may have played his final game for Quetta Gladiators with his coach Moin Khan now questioning his place in the team.

GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma - Vimarsana News

GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma

GPCR Therapeutics, Inc., a venture-backed, clinical stage, international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, announced today the initiation of their phase 2 trial in the US for its lead small molecule asset, GPC-100 ...

GPCR Therapeutics Expands Scientific Advisory Board - Vimarsana News

GPCR Therapeutics Expands Scientific Advisory Board

Seoul, South Korea, 29 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, today announced four appointments to its Scientific Advisory Board (SAB...